SCHEMBL7311340

SCHEMBL7311340

CCCCC(NCC(CC(C)C)NC(=O)c1ccccc1F)C(=O)CSCc1ccco1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 3/20 0.40
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
ALDH1A1 P00352 6/20 0.36
USP2 O75604 2/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CTSL P07711 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7312708 0.94 ALDH1A1 (0.37) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL8686191 0.91 PSMB5 (0.37) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL7311648 0.91 PSMB5 (0.37) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL7305075 0.91 CYP1A2 (0.42) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL7306052 0.91 ALDH1A1 (0.38) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL7311319 0.91 ALDH1A1 (0.37) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL8681390 0.91 CYP1A2 (0.36) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL7306114 0.90 ALDH1A1 (0.36) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL7311350 0.89 TAS1R3 (0.38) POLBMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL7431350 0.89 NPC1 (0.39) POLBMAPTHPGDALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525420-B1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors MITSUBISHI CHEM CORP (JP) 1999-05-12 EP disclosed
US-5834508-A PROTEASE ENZYME INHIBITORS; MUSCLE DISORDERS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-11-10 US disclosed
US-5639783-A POTENT PROTEASE INHIBITOR FOR TREATING MUSCULAR, NERVOUS SYSTEM DISEASES MITSUBISHI CHEMICAL CORPORATION (JP) 1997-06-17 US disclosed
EP-0525420-A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors Mitsubishi Chemical Corporation (JP) 1993-02-03 EP disclosed